μ-opioid receptors present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius

Sue Aicher, Alla Goldberg, Sarita Sharma, Virginia M. Pickel

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Ligands of the μ-opiate receptor (MOR) are known to influence many functions that involve vagal afferent input to the nucleus tractus solitarius (NTS), including cardiopulmonary responses, gastrointestinal activity, and cortical arousal. The current study sought to determine whether a cellular substrate exists for direct modulation of vagal afferents and/or their neuronal target in the NTS by ligands of the MOR. Anterograde tracing of vagal afferents arising from the nodose ganglion was achieved with biotinylated dextran amine (BDA), and the MOR was detected by using antipeptide MOR antiserum. The medial subdivision of the intermediate NTS was examined by electron microscopy for the presence of peroxidase-labeled, BDA- containing vagal afferents and immunogold MOR labeling. MOR was present in both presynaptic axon terminals and at postsynaptic sites, primarily dendrites. In dendrites, MOR immunogold particles usually were located along extrasynaptic portions of the plasma membrane. Of 173 observed BDA-labeled vagal afferent axon terminals, 33% contained immunogold labeling for MOR within the axon terminal. Many of these BDA-labeled terminals formed asymmetric, excitatory, type synapses with dendrites, some of which contained MOR immunogold labeling. MORs were present in 19% of the dendrites contacted by BDA-labeled terminals but were present rarely in both the vagal afferent and its dendritic target. Together, these results suggest that MOR ligands modulate either the presynaptic release from or the postsynaptic responses to largely separate populations of vagal afferents in the intermediate NTS. These results provide a cellular substrate for direct actions of MOR ligands on primary visceral afferents and their second-order neuronal targets in NTS. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalJournal of Comparative Neurology
Volume422
Issue number2
DOIs
StatePublished - Jun 26 2000
Externally publishedYes

Fingerprint

Solitary Nucleus
Opioid Receptors
Presynaptic Terminals
Dendrites
Ligands
Visceral Afferents
Nodose Ganglion
Arousal
Synapses
Peroxidase
Immune Sera
Electron Microscopy
Cell Membrane
biotinylated dextran amine
Population

Keywords

  • Cardiovascular
  • Electron microscopy
  • Immunocytochemistry
  • Nucleus of the solitary tract
  • Opiate receptors
  • Vagus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

μ-opioid receptors present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. / Aicher, Sue; Goldberg, Alla; Sharma, Sarita; Pickel, Virginia M.

In: Journal of Comparative Neurology, Vol. 422, No. 2, 26.06.2000, p. 181-190.

Research output: Contribution to journalArticle

@article{f3bb21f6bd9d4502a98f16fa379a86e3,
title = "μ-opioid receptors present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius",
abstract = "Ligands of the μ-opiate receptor (MOR) are known to influence many functions that involve vagal afferent input to the nucleus tractus solitarius (NTS), including cardiopulmonary responses, gastrointestinal activity, and cortical arousal. The current study sought to determine whether a cellular substrate exists for direct modulation of vagal afferents and/or their neuronal target in the NTS by ligands of the MOR. Anterograde tracing of vagal afferents arising from the nodose ganglion was achieved with biotinylated dextran amine (BDA), and the MOR was detected by using antipeptide MOR antiserum. The medial subdivision of the intermediate NTS was examined by electron microscopy for the presence of peroxidase-labeled, BDA- containing vagal afferents and immunogold MOR labeling. MOR was present in both presynaptic axon terminals and at postsynaptic sites, primarily dendrites. In dendrites, MOR immunogold particles usually were located along extrasynaptic portions of the plasma membrane. Of 173 observed BDA-labeled vagal afferent axon terminals, 33{\%} contained immunogold labeling for MOR within the axon terminal. Many of these BDA-labeled terminals formed asymmetric, excitatory, type synapses with dendrites, some of which contained MOR immunogold labeling. MORs were present in 19{\%} of the dendrites contacted by BDA-labeled terminals but were present rarely in both the vagal afferent and its dendritic target. Together, these results suggest that MOR ligands modulate either the presynaptic release from or the postsynaptic responses to largely separate populations of vagal afferents in the intermediate NTS. These results provide a cellular substrate for direct actions of MOR ligands on primary visceral afferents and their second-order neuronal targets in NTS. (C) 2000 Wiley-Liss, Inc.",
keywords = "Cardiovascular, Electron microscopy, Immunocytochemistry, Nucleus of the solitary tract, Opiate receptors, Vagus",
author = "Sue Aicher and Alla Goldberg and Sarita Sharma and Pickel, {Virginia M.}",
year = "2000",
month = "6",
day = "26",
doi = "10.1002/(SICI)1096-9861(20000626)422:2<181::AID-CNE3>3.0.CO;2-G",
language = "English (US)",
volume = "422",
pages = "181--190",
journal = "Journal of Comparative Neurology",
issn = "0021-9967",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - μ-opioid receptors present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius

AU - Aicher, Sue

AU - Goldberg, Alla

AU - Sharma, Sarita

AU - Pickel, Virginia M.

PY - 2000/6/26

Y1 - 2000/6/26

N2 - Ligands of the μ-opiate receptor (MOR) are known to influence many functions that involve vagal afferent input to the nucleus tractus solitarius (NTS), including cardiopulmonary responses, gastrointestinal activity, and cortical arousal. The current study sought to determine whether a cellular substrate exists for direct modulation of vagal afferents and/or their neuronal target in the NTS by ligands of the MOR. Anterograde tracing of vagal afferents arising from the nodose ganglion was achieved with biotinylated dextran amine (BDA), and the MOR was detected by using antipeptide MOR antiserum. The medial subdivision of the intermediate NTS was examined by electron microscopy for the presence of peroxidase-labeled, BDA- containing vagal afferents and immunogold MOR labeling. MOR was present in both presynaptic axon terminals and at postsynaptic sites, primarily dendrites. In dendrites, MOR immunogold particles usually were located along extrasynaptic portions of the plasma membrane. Of 173 observed BDA-labeled vagal afferent axon terminals, 33% contained immunogold labeling for MOR within the axon terminal. Many of these BDA-labeled terminals formed asymmetric, excitatory, type synapses with dendrites, some of which contained MOR immunogold labeling. MORs were present in 19% of the dendrites contacted by BDA-labeled terminals but were present rarely in both the vagal afferent and its dendritic target. Together, these results suggest that MOR ligands modulate either the presynaptic release from or the postsynaptic responses to largely separate populations of vagal afferents in the intermediate NTS. These results provide a cellular substrate for direct actions of MOR ligands on primary visceral afferents and their second-order neuronal targets in NTS. (C) 2000 Wiley-Liss, Inc.

AB - Ligands of the μ-opiate receptor (MOR) are known to influence many functions that involve vagal afferent input to the nucleus tractus solitarius (NTS), including cardiopulmonary responses, gastrointestinal activity, and cortical arousal. The current study sought to determine whether a cellular substrate exists for direct modulation of vagal afferents and/or their neuronal target in the NTS by ligands of the MOR. Anterograde tracing of vagal afferents arising from the nodose ganglion was achieved with biotinylated dextran amine (BDA), and the MOR was detected by using antipeptide MOR antiserum. The medial subdivision of the intermediate NTS was examined by electron microscopy for the presence of peroxidase-labeled, BDA- containing vagal afferents and immunogold MOR labeling. MOR was present in both presynaptic axon terminals and at postsynaptic sites, primarily dendrites. In dendrites, MOR immunogold particles usually were located along extrasynaptic portions of the plasma membrane. Of 173 observed BDA-labeled vagal afferent axon terminals, 33% contained immunogold labeling for MOR within the axon terminal. Many of these BDA-labeled terminals formed asymmetric, excitatory, type synapses with dendrites, some of which contained MOR immunogold labeling. MORs were present in 19% of the dendrites contacted by BDA-labeled terminals but were present rarely in both the vagal afferent and its dendritic target. Together, these results suggest that MOR ligands modulate either the presynaptic release from or the postsynaptic responses to largely separate populations of vagal afferents in the intermediate NTS. These results provide a cellular substrate for direct actions of MOR ligands on primary visceral afferents and their second-order neuronal targets in NTS. (C) 2000 Wiley-Liss, Inc.

KW - Cardiovascular

KW - Electron microscopy

KW - Immunocytochemistry

KW - Nucleus of the solitary tract

KW - Opiate receptors

KW - Vagus

UR - http://www.scopus.com/inward/record.url?scp=0034717937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034717937&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9861(20000626)422:2<181::AID-CNE3>3.0.CO;2-G

DO - 10.1002/(SICI)1096-9861(20000626)422:2<181::AID-CNE3>3.0.CO;2-G

M3 - Article

VL - 422

SP - 181

EP - 190

JO - Journal of Comparative Neurology

JF - Journal of Comparative Neurology

SN - 0021-9967

IS - 2

ER -